Anzeige
Mehr »
Freitag, 31.10.2025 - Börsentäglich über 12.000 News
Weltweiter Kaliboom treibt Nachfrage - ACM positioniert sich im 93,5 Mrd. USD-Markt bis 2032!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA7 | ISIN: CA2059531020 | Ticker-Symbol: YU1
Frankfurt
30.10.25 | 08:01
0,346 Euro
+2,37 % +0,008
1-Jahres-Chart
CONAVI MEDICAL CORP Chart 1 Jahr
5-Tage-Chart
CONAVI MEDICAL CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,2760,46630.10.

Aktuelle News zur CONAVI MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiConavi Medical Corp: Conavi gets Ontario funding for imaging system launch1
23.10.Conavi Medical Corp.: Conavi Medical to Highlight Novasight Hybrid Imaging at TCT 20252
23.10.Conavi Medical Corp: Conavi Medical best efforts prospectus offering1
16.10.Conavi Medical Corp.: Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 20251
CONAVI MEDICAL Aktie jetzt für 0€ handeln
16.09.Conavi Medical Corp: Conavi submits Novasight imaging system to FDA1
16.09.Conavi submits next-gen intravascular imaging system to FDA1
29.08.Conavi Medical GAAP EPS of -C$0.052
29.08.Conavi Medical Corp.: Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights420US FDA 510(k) submission remains on track for calendar Q3 2025Successful validation testing of Novasight Hybrid system with key opinion leaders Recent academic publications underscore importance of...
► Artikel lesen
30.07.Conavi Medical Corp: Conavi sees publication of Novasight system case report2
30.07.Conavi Medical Corp.: Novasight Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case1
23.07.Conavi Medical Corp: Conavi notes study recommends intracoronary imaging use2
23.07.Conavi Medical Corp.: Conavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCI1
18.06.Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) Investor Webinar with Presentation and Audience Q&A1
03.06.Conavi Medical Corp: Conavi Medical grants options to buy 5.84M shares1
03.06.Conavi Medical Corp.: Conavi Medical Announces New Grant of Stock Options1
30.05.Conavi Medical GAAP EPS of -C$0.072
30.05.Conavi Medical Corp.: Conavi Medical Reports Fiscal Q2 2025 Interim Results and Operational Highlights1.043New U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight's unique value propositionUpsized $20 million financing...
► Artikel lesen
08.05.Conavi Medical Corp.: Conavi Medical's Novasight Hybrid System Named "Product Innovation of the Year" at 2025 Minnesota Manufacturing Awards1
25.04.CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.200TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. ("CPOINT") announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP ("Juno") acquired 1,875,000 common shares...
► Artikel lesen
25.04.Bloom Burton & Co. Inc.: Conavi Medical to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference377Toronto, Ontario--(Newsfile Corp. - April 25, 2025) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing...
► Artikel lesen
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1